Yahoo · Sep 30, 2026
S&P/TSX Composite Index Falls to Two-Month Low in Choppy Trade As Healthcare Sector Shares Tumble
The S&P/TSX Composite Index dropped to the lowest level in two months mid-morning Wednesday, with sh
AC
NASDAQ · ACB
Aurora Cannabis Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$4.59
Up+$0.13 (+2.91%)
Updated Oct 7, 2026, 7:04 AM
SID Score
6.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 217.76M
- P/E ratio
- 7.31
- Dividend yield
- 0.00%
- 52-week range
- $2.56 – $6.67
- Volume
- 1.94M
- Avg. volume
- 1.65M
Price performance · ACB
ACB price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
ACB closed at $4.59 after 21 trading sessions, up 18.60% for the selected period.
- Last close
- $4.59
- Period change
- +18.60%
- Period low
- $3.73
- Period high
- $4.59
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $4.58 | $4.64 | $4.40 | $4.59 | 1.94M |
| Oct 5, 2026 | $4.37 | $4.65 | $4.30 | $4.46 | 4.63M |
| Oct 2, 2026 | $3.94 | $3.97 | $3.865 | $3.92 | 682.85K |
| Oct 1, 2026 | $3.87 | $3.9499 | $3.845 | $3.90 | 607.48K |
| Sep 30, 2026 | $4.01 | $4.02 | $3.815 | $3.90 | 1.61M |
| Sep 29, 2026 | $4.08 | $4.085 | $4.02 | $4.03 | 225.03K |
| Sep 28, 2026 | $4.08 | $4.12 | $3.975 | $4.09 | 497.04K |
| Sep 25, 2026 | $4.13 | $4.155 | $4.08 | $4.10 | 685.08K |
| Sep 24, 2026 | $4.13 | $4.20 | $4.09 | $4.16 | 692.92K |
| Sep 23, 2026 | $4.26 | $4.30 | $4.18 | $4.22 | 1.35M |
| Sep 22, 2026 | $4.05 | $4.29 | $4.0301 | $4.27 | 1.42M |
| Sep 21, 2026 | $3.88 | $4.05 | $3.87 | $4.03 | 809.29K |
| Sep 18, 2026 | $3.85 | $3.915 | $3.84 | $3.87 | 625.45K |
| Sep 17, 2026 | $3.87 | $3.905 | $3.83 | $3.85 | 510.66K |
| Sep 16, 2026 | $3.82 | $3.87 | $3.775 | $3.83 | 582.43K |
| Sep 15, 2026 | $3.77 | $3.84 | $3.74 | $3.82 | 768.33K |
| Sep 14, 2026 | $3.71 | $3.885 | $3.7056 | $3.81 | 605.85K |
| Sep 11, 2026 | $3.77 | $3.85 | $3.68 | $3.74 | 830.45K |
| Sep 10, 2026 | $3.85 | $3.9099 | $3.72 | $3.73 | 631.26K |
| Sep 9, 2026 | $3.85 | $3.895 | $3.83 | $3.88 | 738.98K |
| Sep 8, 2026 | $3.92 | $3.955 | $3.84 | $3.87 | 723.55K |
Latest ACB news
The latest Smart Investors Daily articles mentioning ACB.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ACB research
Overview
Company profile and research snapshot.
Company profile
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $5.92
- Implied upside
- —
- Analysts
- 9
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | ATB CAPITAL MARKETS | Outperform | — |
| Aug 18, 2026 | TD COWEN | Buy | — |
| Aug 5, 2026 | ROTH CAPITAL PARTNERS | Neutral | — |
| Aug 5, 2026 | CANACCORD GENUITY | Buy | — |
| Aug 5, 2026 | ZUANIC & ASSOCIATES | Neutral | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 29, 2026
'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment
https://www.marijuanamoment.net/dea-judge-pauses-marijuana-rescheduling-hearing-as-opponents-highlight-government-report-detailing-gaps-in-federal-processes/
Yahoo · Sep 26, 2026
Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch.
Hostile takeovers are called hostile for a reason, and this one is getting ugly.
Yahoo · Sep 25, 2026
Aurora And Curaleaf’s Hostile Bid Fight Gets Even Messier
Aurora is asking Alberta regulators to fix what it calls three deficiencies in Curaleaf’s $4 hostile bid, while Curaleaf says the complaints are technicalities and vows to keep fighting.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
